Next |
home / stock / atnm / atnm message board
Subject | By | Source | When |
---|---|---|---|
Been watching the share price and have to | timberwolf7 | investorshub | 04/11/2023 4:24:43 AM |
whytestocks: $ATNM News Article - Actinium Pharmaceuticals Announces Dr. Sergio Giralt to Discuss Po | whytestocks | investorshangout | 02/27/2023 1:05:46 PM |
Results were definitely FDA approvable. Everyone is | Pharmboy46 | investorshub | 02/22/2023 6:38:21 PM |
What's wrong? I don't understand! Down 5$ in | blukky | investorshub | 02/22/2023 6:26:34 PM |
PUMP & DUMP | Lonewolf1 | investorshub | 02/21/2023 9:41:37 PM |
Seems controlled | Jaydixson1 | investorshub | 02/21/2023 2:45:07 PM |
$ATNM PR makes me think I missed something. | timberwolf7 | investorshub | 02/19/2023 5:17:20 PM |
nice run in progress. My | timberwolf7 | investorshub | 02/17/2023 1:17:18 PM |
Just thought I would drop this info on | timberwolf7 | investorshub | 12/31/2022 8:50:36 PM |
Damn.. in MY message that I | timberwolf7 | investorshub | 12/04/2022 12:03:50 PM |
Definitely agree that some of the shine is | Pharmboy46 | investorshub | 11/22/2022 6:50:34 PM |
OK, gave up my shares to the covered calls. | timberwolf7 | investorshub | 11/21/2022 7:21:59 PM |
But imagine if you were one of the | Pharmboy46 | investorshub | 11/04/2022 2:26:11 PM |
It will see the target price IF its | timberwolf7 | investorshub | 11/04/2022 2:25:42 PM |
Got to acknowledge, its NOT the company's fault | timberwolf7 | investorshub | 11/04/2022 2:18:39 PM |
(Also a novice posting). Im just posting on | Pharmboy46 | investorshub | 11/04/2022 1:46:27 PM |
I'm a novice (at best) in this, but | herwilagn | investorshub | 11/04/2022 9:21:32 AM |
I hate to turn into that guy who | Pharmboy46 | investorshub | 11/03/2022 11:35:01 PM |
Got an email from $ATNM this morn talking | timberwolf7 | investorshub | 11/03/2022 4:27:02 PM |
Market valuation, it is what they think the | dinogreeves | investorshub | 11/03/2022 1:25:46 PM |
News, Short Squeeze, Breakout and More Instantly...
Actinium Pharmaceuticals Inc. Company Name:
ATNM Stock Symbol:
NYSE Market:
Actinium to Host KOL Webinar to Discuss Iomab-ACT Commercial CAR T-Cell Therapy Trial Design, Objectives and Potential Market Opportunity PR Newswire - KOL and principal investigator, Dr. Farrukh Awan , Professor of Medicine, Division of Hematology Oncology at Univer...
Actinium Announces Oral Presentation Detailing Improved Survival Outcomes in TP53 Positive Patients at the EHA 2024 Annual Congress and Presentation of Long-Term Efficacy Results in Older Patients Receiving an Iomab-B Led Bone Marrow Transplant in the Phase 3 SIERRA Trial PR Newswire ...
2024-05-13 18:15:03 ET Stephens analyst issues OVERWEIGHT recommendation for ATNM on May 13, 2024 04:22PM ET. ATNM was trading at $8.86 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 2 - Buy recommendati...